MetLife Investment Management’s Duck Creek Technologies, Inc. Common Stock DCT Stock Holding History

MetLife Investment Management’s Portfolio DCT Stock Details DCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-40,216	Closed	-$485K	–	2836
2022 Q4	$485K	Hold	40,216	–	–	﹤0.01%	1665
2022 Q3	$477K	Hold	40,216	–	–	﹤0.01%	1674
2022 Q2	$597K	Buy	40,216 +37,932	+1,661%	+$666K	﹤0.01%	1540
2022 Q1	$50.5K	Buy	+2,284	New	+$54.6K	﹤0.01%	2677

Other funds holding DCT

FDx Advisors Chicago, Illinois $332M AUM 22.76% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MetLife Investment Management's DCT Position: Q1 2023 in Review

MetLife Investment Management sold out of Duck Creek Technologies, Inc. Common Stock (DCT) in Q1 2023, closing a stake of 40,216 shares — an estimated $485K sold.

MetLife Investment Management first reported a position in DCT in Q1 2022 and held it in 4 quarters. The position peaked at $597K in Q2 2022. 4 funds tracked by Wall St. Rank hold DCT as of Q1 2023.

MetLife Investment Management reported no remaining Duck Creek Technologies, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
MetLife Investment Management sold 40,216 Duck Creek Technologies, Inc. Common Stock shares in Q1 2023, an estimated $485K.
MetLife Investment Management first reported a position in Duck Creek Technologies, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
MetLife Investment Management's Duck Creek Technologies, Inc. Common Stock position peaked at $597K in Q2 2022.
4 funds tracked by Wall St. Rank held Duck Creek Technologies, Inc. Common Stock as of Q1 2023.

Based on MetLife Investment Management's 13F filing for Q1 2023, filed 15 May 2023.